Abstract：Objective To explore the expression and diagnostic significance of β-tubulin-Ⅲ proteins,E-cadherin and α-catenin in breast precancerous lesions,including atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and invasive ductal carcinomas (IDC).Methods The expressions of β-tubulin-Ⅲ, E-cadherin and α-catenin were investigated by immunhistochemical UltraSensitiveTM S-P method of precancerous Lesions including 20 cases of ADH,60 cases of DCIS,and 90 cases of carcinoma of the breast. 30 cases of normal breast tissues were selected as a control group.Results (1)Significant differences of the β-tubulin-Ⅲ proteins expression were found among the four groups of normal breast tissues(20%),ADH(55.0%),DCIS(71.7%)and IDC(84.4%),(χ2=22.298,P<0.05),(P<0.05). (2)The expressions of E-cadherin and α-catenin in observed and controll groups:The expressions of E-cadherin in normal group,ADH,DCIS and IDC were 100%,75.0%,68.3% and 41.1%.The expressions of α-catenin in normal group,ADH,DCIS and IDC groups were 100%,80.0%,73.3% and 56.7%.There were significant differences of the expressions of E-cadherin and α-catenin between DCIS and IDC(χ2=18.650,10.970,P<0.05).ConclusionsAbnormal expression of β-tubulin-Ⅲ may be an early event in the development of breast tumor. The aberration of β-tubulin-Ⅲ may play a key role during oncogenesis and promote breast cellular transformation into malignancy. The abnormal expressions of E-cadherin and α-catenin with the degree of breast disease relates to the development, progression and metastasis of breast carcinoma,which may serve as one of the parameters for diagnosis of breast carcinoma and determine biological behavior and prognosis of breast carcinoma.
王刚平 张红 梁云爱 张作峰 袁宗怀 郭小艳. β-tubulin-Ⅲ、E-cadherin 和α-catenin在乳腺癌及癌前病变中的表达及诊断意义[J]. 中华诊断学电子杂志, 2013, 1(1): 57-61.
Wang Gangping,Zhang Hong,Liang Yunai,Zhang Zuofeng,Yuan Zonghuai,Guo Xiaoyan. The expressions and diagnostic significance of β-tubulin-Ⅲ,E-cadherin and α-catenin in precancerous Lesions and carcinoma of the breast. zhzdx, 2013, 1(1): 57-61.
[1]Lakhani SR,Ellis IO,Schnitt SJ,et al.WHO classification of tumours of the breast [M].Lyon,France:IARC Press,2012. [2]Wang GP,Zhang H,Zhang ZF,et al.Clinical and pathological characteristics of intraductal proliferative lesions and coexist with invasive ductal carcinomas [J].Chinses-German J Clin Oncol,2013,12(12): 574-580. [3]王刚平,梁云爱,张作峰,等.CD105标记MVD及HIF-1α在乳腺癌及癌前病变中的表达及意义[J/CD].中华临床医师杂志(电子版),2013,7(16):7386-7391. [4]冯俊,李建军,应荣彪,等.βⅢ-微管蛋白在乳腺癌癌变不同阶段的表达及意义[J/CD].中华临床医师杂志(电子版),2011,5(8):2197-2200. [5]李广慧.E-cadherin和α-catenin在乳腺浸润性导管癌及乳腺癌前病变中的表达及意义[D].大连:大连医科大学.2008. [6]Tanaka K,Iwamoto S,Gon G,et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas[J].Clin Cancer Res,2000,6(1):127-134. [7]Jawhari A,Jordan S,Poole S,et al.Abnormal immuneoreactivity of the E-cadherin/ catenin complex in gastric carcinoma:relationship with patient survival[J]. Gastroenterology,1997,112(1):46-54. [8]Kausilia K,Krishandath,Hugow,et al.Reduced expression of the cadherin complex in oesopnageal adenocarcinoma correcateswith poor prognosis[J].J Pathol ,1997,182: 3. [9]Gritsko T,Williams A,Turkson J,et al.Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells[J].Clin Cancer Res,2006,12(1): 11-19. [10]冶俊玲,韩静绮,郭新建,等.食管鳞癌组织中β微管蛋白Ⅲ、Stathmin和P糖蛋白的表达与预后[J].世界华人消化杂志,2012,20(27):2613-2617. [11]Kam Y,Quaranta V.Cadherin-bound β-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between β-catenin pools[J].PLoS ONE,2009,4(2):e4580. [12]Hulpiau P,Roy FV.Molecular evolution of the cadherin superfamily[J].Znt Biochem Cell Biol,2009,41(2):349-369.
2013, Vol. 1 
